Trek Financial’s Exelixis EXEL Stock Holding History

Trek Financial’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,388	Closed	-$163K	–	242
2022 Q3	$163K	Buy	+10,388	New	+$201K	0.02%	202

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Trek Financial's EXEL Position: Q4 2022 in Review

Trek Financial sold out of Exelixis (EXEL) in Q4 2022, closing a stake of 10,388 shares — an estimated $163K sold.

Trek Financial first reported a position in EXEL in Q3 2022 and held it in 1 quarter. The position peaked at $163K in Q3 2022. 386 funds tracked by Wall St. Rank hold EXEL as of Q4 2022.

Trek Financial reported no remaining Exelixis position as of Q4 2022 after selling out during the quarter.
Trek Financial sold 10,388 Exelixis shares in Q4 2022, an estimated $163K.
Trek Financial first reported a position in Exelixis in Q3 2022 and held it in 1 quarter.
Trek Financial's Exelixis position peaked at $163K in Q3 2022.
386 funds tracked by Wall St. Rank held Exelixis as of Q4 2022.

Based on Trek Financial's 13F filing for Q4 2022, filed 13 Feb 2023.